This site is intended for Healthcare Professionals only
Back to CKS

Cardiovascular Drugs and devices Skin and nail

Compression stockings

Last revised in August 2026

Compression stockings are useful for treating conditions associated with chronic venous insufficiency, including venous ulcers, varicose veins

Compression stockings: Summary

  • Compression therapy is used to manage a range of conditions associated with venous and lymphatic dysfunction.
    • Conditions managed include include chronic venous insufficiency, varicose veins (if interventional treatment is unsuitable), venous eczema, lipodermatosclerosis, post‑thrombotic syndrome, superficial vein thrombosis, lymphoedema, lipoedema, and chronic oedema.
    • Compression is a core component of treatment for venous leg ulcers and for preventing ulcer recurrence.
  • Graduated pressure is provided from the ankle to the calf or thigh, enhancing venous return and improving the efficiency of the calf‑muscle pump.
  • Compression hosiery products vary by compression class, length, material, and toe design. Available types include:
    • Compression stockings.
    • Hosiery kits (for venous leg ulcer healing).
    • Adjustable compression wraps (useful for fluctuating oedema or self‑management).
    • Multilayer bandaging systems (for oedematous or distorted limbs).
    • Flat‑knit garments (for lymphoedema or chronic oedema).
  • In primary care, the following British Standard compression classes are commonly used:
    • Class 1 (mild compression) exert an ankle pressure of 14–17 mmHg.
    • Class 2 (moderate compression) exert an ankle pressure of 18–24 mmHg.
    • Class 3 (strong compression) exert an ankle pressure of 25–35 mmHg.
  • European (RAL) standard garments, which provide higher stiffness and more consistent pressure profiles, may be prescribed by specialist services.
  • Before initiating compression therapy, a holistic lower‑limb assessment, including assessment for possible peripheral arterial disease (PAD), venous disease, limb shape, and skin condition should be carried out.
    • PAD assessment usually includes evaluation of arterial supply using the ankle–brachial pressure index (ABPI), recognising that ABPI may be unreliable in people with diabetes, lymphoedema, chronic oedema, or arterial calcification.
    • In such cases, toe pressures or Doppler waveform analysis may be required.
    • Class 1 compression therapy can be initiated without ABPI, when no red flags for arterial disease are present.
  • Compression therapy should be tailored to the individual.
    • The level of compression should be guided by the clinical condition, vascular assessment, and the person’s ability to apply and tolerate the garment.
    • Below‑knee garments are usually sufficient, although thigh‑length garments may be required when symptoms or swelling extend above the knee.
    • Open‑toe designs may be appropriate for people with toe deformities, fungal infections, or those who choose to wear socks.
  • Compression hosiery should be removed at night unless continuous use has been specifically indicated as part of a structured management plan, such as in lymphoedema care.
  • Stockings should be replaced every 3–6 months, with limb measurements repeated at each replacement to ensure appropriate fit.

Have I got the right topic?

From age 16 years onwards.

This CKS topic covers the use of compression stockings in the management of venous disease affecting the legs. It focuses on general issues, with more specific issues discussed in separate CKS topics which cover the conditions for which compression stockings may be indicated. This topic does not cover the use of anti-embolism stockings in hospital patients, or use of over-the-counter travel compression hosiery. 

There are separate CKS topics on Deep vein thrombosis, Dermatitis - contact, Eczema - atopic, Leg ulcer - venous, Superficial vein thrombosis (superficial thrombophlebitis), Varicose veins, and Venous eczema and lipodermatosclerosis.

The target audience for this CKS topic is healthcare professionals working within the NHS in the UK, and providing first contact or primary healthcare.

How up-to-date is this topic?

Changes

August 2026 — minor update. Following feedback from the Leg Ulcer service, minor wording changes were made to the assessment section, and a note was added that VLU healing requires compression greater than 40mmHg.

Previous changes

April 2026 — reviewed. A literature search was conducted in April 2026 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of this topic. The topic has been aligned with the 2020 National Wound Care Strategy Programme consensus document Recommendations for lower limb ulcers, the 2021 Wounds UK Best practice statement Compression hosiery; a patient-centric approach, the 2023 Wounds UK Best Practice Statement The use of compression therapy for peripheral oedema: considerations in people with heart failure, and the 2025 Wounds UK guidance Compression hosiery for the prevention of recurrent leg ulceration: Evidence, efficacy and best practice.

March 2026 — minor update. Minor update to assessment section.

February 2026 — minor update. Minor update to assessment section.

May 2022 — reviewed. A literature search was conducted in April 2022 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. Updated literature has been incorporated to provide supporting evidence for the guidance. No major changes to the clinical recommendations have been made.

September 2018 — minor update. Changes made to recommendations on the use of elastic graduated compression stockings to prevent post-thrombotic syndrome or VTE recurrence after a proximal DVT to align with NICE guideline CG144.

September to October 2017 — reviewed. A literature search was conducted in September 2017 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. 

May 2014 — minor update. Minor change to text to clarify interpretation of ankle-brachial pressure index measurements in Assessment section.

September 2012 — reviewed. A literature search was conducted in September 2012 to identify evidence-based guidelines, UK policy, systematic reviews, and key RCTs published since the last revision of the topic. No changes to clinical recommendations have been made.

June 2010 — minor update. The recommendation on the class of compression stockings to use to prevent the recurrence of deep vein thrombosis, or the development of post-thrombotic syndrome, has been updated.

July to October 2008 — this is a new CKS topic. The evidence-base has been reviewed in detail, and recommendations are clearly justified and transparently linked to the supporting evidence.

Update

New evidence

Evidence-based guidelines

No new evidence-based guidelines since 1 April 2026.

HTAs (Health Technology Assessments)

No new HTAs since 1 April 2026.

Economic appraisals

No new economic appraisals relevant to England since 1 April 2026.

Systematic reviews and meta-analyses

No new systematic reviews or meta-analysis which reach the CKS threshold for inclusion since 1 April 2026.

Primary evidence

No new primary evidence which reaches the CKS threshold for inclusion published since 1 April 2026.

New policies

No new national policies or guidelines since 1 April 2026.

New safety alerts

No new safety alerts since 1 April 2026.

Changes in product availability

No changes in product availability since 1 April 2026.

Goals and outcome measures

Goals

To support primary healthcare professionals to:

  • Understand the indications for use of compression systems.
  • Carry out a holistic lower‑limb assessment before prescribing compression garments.
  • Select the most appropriate garment type based on clinical need, limb shape, the person's preference, and ability to apply the device.
  • Provide advice to the person on safe and appropriate use of compression garments.

Outcome measures

No outcome measures were found during the review of this topic.

Audit criteria

No audit criteria were found during the review of this topic.

QOF indicators

No QOF indicators were found during the review of this topic.

QIPP - Options for local implementation

No QIPP indicators were found during the review of this topic.

NICE quality standards

No NICE quality standards were found during the review of this topic.

Background information

What are compression garments?

  • Compression garments are a medical device used to manage a range of conditions associated with venous and lymphatic disease, including varicose veins (if interventional treatment is unsuitable), chronic venous insufficiency, venous leg ulcers, venous eczema, lipodermatosclerosis, post‑thrombotic syndrome, superficial vein thrombosis, lymphoedema, lipoedema, and chronic oedema.
  • Compression therapy aims to improve venous return, reduce venous hypertension, and support the function of the calf‑muscle pump.
  • Compression garments provide graduated pressure from the distal to the proximal leg, enhancing venous blood flow and reducing oedema.
  • Types of compression garment include:
    • Compression stockings.
    • Hosiery kits.
    • Adjustable compression wraps.
    • Multilayer bandaging systems.
    • Flat‑knit garments.
  • Garments vary by compression class, length (below‑knee or thigh‑length), colour, size, fabric type, stiffness, and whether they enclose the toes (closed‑toe) or leave them free (open‑toe).
    • Stiffer fabrics (such as flat‑knit garments) may be required for people with lymphoedema, chronic oedema, or limb shape distortion.
  • In primary care, compression products typically follow the British Standard classification based on the pressure they exert:
    • Class 1 (mild compression): 14–17 mmHg.
    • Class 2 (moderate compression): 18–24 mmHg.
    • Class 3 (strong compression): 25–35 mmHg.
  • Specialist services may prescribe European (RAL) standard garments, which provide higher and more consistent compression within each class.
    • For example, RAL Class 2 provides 23–32 mmHg, and higher classes (Class 3 and Class 4) are available for more complex lymphatic or venous conditions.
  • Graduated compression tights are available but cannot be prescribed on the NHS; they may be purchased privately from pharmacies or manufacturers.

[NWCSP, 2020; Wounds UK, 2021; Wounds UK, 2025; BNF, 2026]

Management

Scenario: Compression garments

From age 16 years onwards.

What assessment should I carry out before prescribing compression therapy?

  • Carry out a full lower‑limb assessment before prescribing compression therapy, including consideration of red flags, assessment of arterial supply, venous disease, limb shape, and skin condition.
  • Assess for possible peripheral arterial disease (PAD) by:
    • Asking about risk factors for PAD including the person's smoking status and comorbidities (such as diabetes, cardiovascular events, hypertension, hyperlipidaemia, chronic kidney disease), as well as family history of PAD.
    • Reviewing the person's surgical history for any arterial or venous interventions.
    • Reviewing the person's current medication (for example, angiotensin-converting enzyme (ACE) inhibitors, immunosuppressants, or corticosteroids).
    • Asking about the presence and severity of possible symptoms of intermittent claudication (such as muscle pain and fatigue in the buttock, thigh, calf or ankle, which occurs during exercise, and is relieved by rest) and critical limb ischaemia (such as intense leg or foot pain when resting). Be aware that critical limb ischaemia can also be suggested by ulceration.
    • Checking the femoral, popliteal, and foot pulses.
  • Measure ankle-brachial pressure index (ABPI) using Doppler assessment to help identify peripheral arterial disease.
    • ABPI should be interpreted alongside clinical findings, as it may be unreliable in people with diabetes, chronic oedema, lymphoedema, or arterial calcification.
      • Toe-brachial pressure index (TBPI) or Doppler waveform analysis may be required when ABPI is unreliable.
    • Use the following thresholds to guide compression therapy:
      • ABPI less than 0.5  — severe arterial insufficiency is likely. Compression therapy is contraindicated. Urgent vascular assessment is required.
      • ABPI 0.5–0.79  — mixed arterial and venous disease is likely. Modified or light compression may be used with caution, supported by clinical monitoring and specialist advice where needed.
      • ABPI 0.8–1.3 — no significant arterial disease. Full compression therapy is generally considered safe.
      • ABPI greater than 1.3–1.4 — arteries may be calcified and incompressible. ABPI is unreliable. Further vascular assessment (for example, TBPI) is required before prescribing compression.
      • Note: ABPI is not required before initiating light compression - 20 mmHg (for example, Class 1 stockings) when no red flags for arterial disease are present.
  • Assess the legs for possible venous disease:
    • May be suggested by varicose veins, venous dermatitis, haemosiderin deposition (brawny oedema), lipodermatosclerosis, atrophie blanche, and healed or active venous ulcers. 
  • Also examine the skin for signs of fragility, dermatitis, infection, or wounds.
  • Assess limb shape, oedema, and tissue quality to determine the most appropriate compression system.
    • People with significant oedema, limb distortion, or deep skin folds may require flat‑knit garments, adjustable compression wraps, or bandaging, rather than standard circular‑knit stockings.
  • Assess the person’s ability to apply and remove compression.
    • Conditions such as arthritis, reduced hand strength, or limited mobility may make it difficult to manage stockings independently.
    • Donning aids, alternative garment types, or support from carers may be required.
  • Compression therapy should be delayed and further assessment/appropriate specialist referral undertaken if any of the following are present:
    • Suspected acute or chronic limb ischaemia.
    • Acute or rapidly worsening infection of leg or foot (suggested by unilateral redness, swelling, pain, pus, heat).
    • Symptoms of sepsis.
    • Suspected deep vein thrombosis (compression may be used once pain allows, diagnosis is confirmed and treatment has been started).
    • Acute decompensated heart failure.
    • Suspected skin cancer.

Basis for recommendation

These recommendations are largely based on the National Institute for Health and Care Excellence (NICE) guideline Peripheral arterial disease: diagnosis and management [NICE, 2020], the NICE HealthTech guidance Compression products for treating venous leg ulcers: late-stage assessment [NICE, 2025a], the Wounds UK guidance on Compression hosiery for the prevention of recurrent leg ulceration: Evidence, efficacy and best practice [Wounds UK, 2025] and Best practice statement: Compression hosiery; a patient-centric approach [Wounds UK, 2021], the National Wound Care Strategy Programme's consensus document Recommendations for lower limb ulcers [NWCSP, 2020] the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guideline for the Management of Lower Extremity Peripheral Artery Disease [Gornik, 2025], and the British Lymphology Society position document Assessing vascular status in the presence of chronic oedema prior to the application of compression hosiery [BLS, 2019].

ABPI assessment
  • Wounds UK states that an ABPI assessment is recommended before commencing compression therapy greater than 20mmHg. In the presence of significant peripheral arterial disease (PAD), compression therapy can be dangerous and should only be used at the recommendation of a vascular specialist. However, compression up to 20mmHg can be applied in the absence of red flags for PAD without any form of arterial assessment [Wounds UK, 2021].

How should I choose the most appropriate compression system?

  • Ensure that the compression system is chosen in collaboration with the person through a shared decision-making process.
  • Choose an appropriate compression system based on the person's underlying condition, limb shape, oedema, skin condition, ability to apply the device, and personal preference.
    • Be aware that compression up to 20 mmHg can be applied without any form of arterial assessment if there are no red flags.
  • Options include:
    • Compression stockings (British Standard or RAL).
    • Hosiery kits, consisting of two compression garments worn one over the other (for venous leg ulcer healing).
    • Adjustable compression wraps (useful for fluctuating oedema or self‑management).
    • Multilayer bandaging systems (for oedematous or distorted limbs).
    • Flat‑knit garments (for lymphoedema or chronic oedema).
  • Consider how the choice of compression product might affect the person's quality of life, including:
    • Ability to complete activities of daily living
    • Adherence to the treatment regimen
    • Physical health, including whether they can apply products themselves
    • Mental health and wellbeing
    • Relationships with others, including whether they have informal carer support at home
  • Select the degree of compression:
    • This should be guided by the person's underlying condition (see below), but may need to be reduced to the highest level the person can tolerate safely.
    • Increase compression strength gradually if needed.
    • Reduce compression if pain, numbness, or skin damage occurs.
  • Use mild compression (Class 1; 14–17 mmHg) for:
    • Mild venous symptoms.
    • People unable to tolerate higher compression.
    • Superficial vein thrombosis when Class 2 is painful.
    • Initial management when ABPI is borderline, or the person is awaiting further vascular assessment.
    • Varicose veins with symptoms.
      • Note: compression therapy is not a first-line treatment for varicose veins and should only be offered if interventional treatment is unsuitable, such as during pregnancy.
      • For more information, see the CKS topic on Varicose veins
    • Venous eczema.
    • Lipodermatosclerosis.
  • Use moderate compression (Class 2; 18–24 mmHg) for:
  • Use strong compression (Class 3; 25–35 mmHg) for:
    • Severe venous insufficiency.
    • Healing of venous leg ulcers (therapeutic dose is > 40 mmHg).
    • Prevention of venous ulcer recurrence.
    • Persistent venous eczema or lipodermatosclerosis not controlled with Class 2.
    • Post‑thrombotic syndrome.
    • Mild to moderate oedema requiring stronger compression
    • Chronic oedema/lymphoedema.
  • Refer to a specialist service for initiation of high‑stiffness compression systems for people with:
    • Chronic oedema/lymphoedema requiring stronger containment.
    • Chronic oedema with fibrosis.
    • Limb‑shape distortion.
    • Deep skin folds.
    • Rapidly fluctuating oedema (adjustable wraps may be required).
      • Note: the most appropriate specialist service for referral may vary locally.
  • Use below‑knee garments for most venous and lymphatic conditions.
  • Use thigh‑length garments (or tights) only when swelling or varicosities extend above the knee.
  • Select toe style based on need:
    • Use open‑toe garments for toe deformities, fungal infection, long foot length, or when socks are required over the stocking.
    • Use closed‑toe garments for comfort and warmth where no contraindications exist (such as diabetic neuropathy).
  • Provide at least two garments (or two pairs if used on both legs), so that one can be worn while the other is being washed and dried.
  • Ensure that compression garments are replaced every 3–6 months, or sooner if any stretching, defects, or damage become apparent.

Basis for recommendation

These recommendations are largely based on the Wounds UK Best practice statement Compression hosiery; a patient-centric approach [Wounds UK, 2021], the Wounds UK Best Practice Statement The use of compression therapy for peripheral oedema: considerations in people with heart failure [Wounds UK, 2023], and the Wounds UK guidance Compression hosiery for the prevention of recurrent leg ulceration: Evidence, efficacy and best practice [Wounds UK, 2025], the National Wound Care Strategy Programme consensus document Recommendations for lower limb ulcers [NWCSP, 2020] , the National Institute of Health and Care Excellence (NICE) HealthTech guidance Compression products for treating venous leg ulcers: late-stage assessment [NICE, 2025a], and the NICE guideline Varicose veins: diagnosis and management [NICE, 2025b], as well as evidence from a number of Cochrane systematic reviews.

  • Recommendations about compression strengths for varicose veins, venous eczema, lipodermatosclerosis, and atrophie blanche largely derive from the Wounds UK guidance Best Practice Statement: Compression hosiery: a patient-centric approach [Wounds UK, 2021].
  • The recommendation that compression therapy should only be used for varicose veins if interventional treatment (such as endothermal ablation, ultrasound‑guided foam sclerotherapy, or surgery) is unsuitable is based on expert opinion within the NICE guideline Varicose veins: diagnosis and management [NICE, 2025b].
  • Information on the use of compression therapy for treating and preventing the recurrence of leg ulcers is based on the NICE HealthTech guidance Compression products for treating venous leg ulcers: late-stage assessment [NICE, 2025a], the National Wound Care Strategy Programme consensus document Recommendations for lower limb ulcers [NWCSP, 2020] and the Wounds UK guidance Compression hosiery for the prevention of recurrent leg ulceration: Evidence, efficacy and best practice [Wounds UK, 2025].
    • NICE recommends strong compression (at least 40 mmHg of pressure at the ankle), for the treatment of venous leg ulcers [NICE, 2025a]. 
    • The National Wound Care Strategy Programme advises 'strong compression' for leg wounds secondary to venous insufficiency. Two-layer compression hosiery kits are recommended as first line treatment [NWCSP, 2020].
    • Wounds UK cites good evidence that pressure of at least 40mmHg at the ankle is needed to optimise healing of leg ulcers [Wounds UK, 2025].
    • There is also good evidence that higher compression levels are more effective at preventing leg ulcer recurrence.
      • A 2024 Cochrane review found that class 3 compression stockings are the most effective at reducing risk of recurrence and are more effective than class 2, but acknowledged that higher compression may lead to lower concordance with treatment [de Moraes Silva, 2024].
    • The Wounds UK guideline advises that a routine ‘step-down’ approach post-healing should be avoided. Instead clinicians should consider maintaining compression at 40 mmHg for long-term prevention, but the decision should be individualised with emphasis on shared decision making [Wounds UK, 2025].
    • CKS therefore recommends considering the use of strong compression systems as these achieve ankle pressure closest to 40 mmHg but also acknowledges that lower compression levels may aid adherence to treatment.
  • Recommendations on use of compression therapy to treat oedema and lymphodema derive from the National Wound Care Strategy Programme consensus document Recommendations for lower leg ulcers [NWCSP, 2020] and the Wounds UK best practice statements Compression hosiery: a patient-centric approach [Wounds UK, 2021] and The use of compression therapy for peripheral oedema: considerations in people with heart failure [Wounds UK, 2023].
    • The NWCSP states that people with any of chronic ankle/leg oedema not reduced by elevation; abnormal limb shape; copious exudate, or very fragile skin should be offered strong multi-component compression bandaging and if this does not improve symptoms, the person should be offered specialist referral for expert diagnosis and advice about lymphoedema [NWCSP, 2020]. 
    • Wounds UK states that a made-to-measure medical compression hosiery garment may be more practical for people with oedema as it can be measured to the patient’s limb size and shape [Wounds UK, 2021].
  • Evidence on the use of compression therapy for treating post‐thrombotic syndrome is summarized in a 2019 Cochrane systematic review [Azirar, 2019].
    • The review concluded that the only available evidence was from two small, short duration studies which provided very low‐certainty regarding the effectiveness of compression stockings for the treatment of post‐thrombotic syndrome.  
    • A subsequent RCT which was curtailed due to the COVID-19 pandemic found that the incidence of post-thrombotic syndrome was lower in an intervention arm receiving anticoagulation plus use of compression stockings; versus a control arm receiving anticoagulation only (30% vs. 51%). However, the small sample size (76 in each group) precluded statistical analysis [Thapar, 2025].
    • High‐certainty evidence to support the use of compression therapy in the prevention of post‐thrombotic syndrome is therefore lacking.
  • Evidence on the use of compression therapy for treating superficial vein thrombosis is summarized in a 2018 Cochrane systematic review [Di Nisio, 2018].
    • There is limited evidence to show the clinical benefit of compression therapy in preventing venous thromboembolism and progression of superficial vein thrombosis [Di Nisio, 2018]. However, compression stockings (class 1 or 2) are commonly recommended for relieving itchiness, pain and swelling, and providing comfort.
  • For further evidence and guidance on the use of compression stockings in venous disorders, see the individual CKS topics on the specific conditions being treated.

How do I ensure that the stocking fits the person correctly?

  • The efficacy of compression stockings is reliant on ensuring the person's leg is accurately measured and that garments are fitted correctly.
  • Compression stockings are available in several ready-made sizes — the choice is determined by measuring the person's leg.
    • This can be undertaken in the pharmacy when dispensing a prescription for compression stockings (a payment can be claimed for this service).
    • If this is not possible, the person or their carer may be asked to take the measurements (if capable), or the person should be referred back to the prescriber for alternative arrangements to be made.
  • In general, when measuring the person:
    • If stockings are to be worn on both legs, measure each leg to exclude a significant discrepancy in size (in which case, two differently sized stockings will need to be ordered).
    • Take measurements directly against the skin to ensure accuracy. Using a skin marker may help to ensure accuracy through re-checking measurements. 
    • Measurements that need to be taken vary depending on the stocking manufacturer (specific measuring guides are available), but in general, the following need to be obtained for below-knee stockings (taken with the person seated, and feet flat on the floor):
      • Circumference of the ankle, at the narrowest point just above the ankle bone (malleoli).
      • Circumference of the widest part of the calf (usually the mid-calf area).
      • Length of the foot from the heel to the tip of the longest toe (if a closed-toe stocking is required).
    • If a thigh-length stocking is prescribed, also measure around the widest part of the thigh.
    • If the person has a swollen leg, measurements should be taken first thing in the morning — this may require a visit by a community nurse.
    • If the person has skin folds due to oedema or the limb is particularly misshapen, specialist assessment may be required.
    • Severely swollen legs may first require a period of compression bandaging.
  • Made-to-measure stockings may be required if the person has a deformity affecting the leg or if a correctly sized ready-made stocking cannot be obtained based on the leg measurements. State 'made to measure' on the prescription.
    • Note: If a pharmacist, on measuring a person for ready-made stockings, identifies that a made-to-measure stocking is required, they can endorse the prescription with 'made to measure' and be reimbursed appropriately.
    • The pharmacist will complete a manufacturer's order form, which will specify the measurements required. If the pharmacist cannot take the measurements (for example, the person is unable to attend the pharmacy), a member of the primary healthcare team may need to measure the person.
    • As with ready-made stockings, if the leg is swollen, measurements are best taken first thing in the morning or after a period of compression bandaging.
  • Ideally, each time a stocking is replaced, the leg should be re-measured.

Basis for recommendation

These recommendations are based on the Wounds UK guidance Best Practice Statement: Compression hosiery: a patient-centric approach [Wounds UK, 2021], the Prescription Pricing Authority (PPA) Drug tariff Part IXA-Appliances; Elastic Hoisery [PPA, 2022], and on what CKS considers good clinical practice.

What information and advice should I offer?

  • Ensure that the person knows:
    • The reasons for, and the benefits of, wearing compression garments.
    • How to put on and remove the garment, and is able to do so.
      • If the person is having difficulty, an application aid can be prescribed (for example, ActiGlide®).
    • That the best time to apply compression is first thing in the morning, before any leg swelling develops.
    • When and how to reorder their compression garments.
    • When to seek medical advice.
  • Check that the person is satisfied with:
    • The fit — if standard sizes are not suitable, a made-to-measure garment may be needed.
    • The level of compression — if the person cannot tolerate the level of compression, consider reducing the strength.
    • The length — if the person is having difficulty using a thigh-length garment, consider switching to a below-knee garment (thigh-length garments are not usually necessary unless there are severe varicose veins above the knee, or there is swelling which extends above the knee).
    • The colour of the garment.
  • Advise that:
    • The compression garment should be taken off at bedtime unless continuous use has been specifically advised as part of a structured management plan, such as in lymphoedema care.
    • An emollient should be applied while the garment is off, to reduce skin dryness and irritation.
    • The person should be offered regular review, with the garment replaced every 3–6 months to ensure continued good fit and the correct level of compression.
    • The garment should be replaced sooner if any stretching, defects, or damage become apparent.
    • The life of the garment can be prolonged by correct washing. For example, stockings should be hand-washed at about 40°C (a comfortable hand temperature) and dried away from direct heat.
  • If adherence to treatment is an issue, consider discussing with the person that:
    • Compression is a long-term therapy that could be viewed in the same way as long-term drug treatment.
    • Compromise between the person's preference and clinical need may be required.
    • Lower compression can be used if high compression is not initially tolerated.
    • As tolerance builds over time, compression levels may be increased
    •  Factors that make compression more tolerable may include skin care, elevation, activity, weight loss, and access to support groups.

Basis for recommendation

These recommendations are based on the Wounds UK guidance Best Practice Statement: Compression hosiery: a patient-centric approach [Wounds UK, 2021], and on what CKS considers good clinical practice.

  • Wounds UK acknowledges that patient adherence to compression therapy is often poor. The guideline emphasises the importance of shared decision making and suggests that appropriate provision of information and advice may increase adherence.

How frequently should a person be reviewed?

  • Review every 3–6 months to:
    • Reassess the condition for which compression therapy is being prescribed.
    • Ensure that the person is continuing to wear the compression device successfully and is replacing it regularly.
  • Ask the person to wear their compression device for the review appointment, so that the fit can be re-evaluated.
    • Repeat leg measurements to ensure continued correct fit.
    • Assess the fit – the device should not feel loose, and the fabric should be evenly distributed. Knee-length systems should sit two fingers’ width below the knee crease, and thigh-length systems should sit four fingers’ width below the gluteal fold. Material should not pinch the skin or cause pain.
  • Review people with neuropathy, frailty, or fragile skin on a more regular basis, with an appropriate interval determined by clinical judgement
  • Ideally, Doppler studies should be repeated every 6–12 months or earlier if clinically indicated. Follow local policies, if available.

Basis for recommendation

These recommendations are based on the Wounds UK Best Practice Statements Compression hosiery: a patient-centric approach [Wounds UK, 2021] and The use of compression therapy for peripheral oedema: considerations in people with heart failure [Wounds UK, 2023]; expert opinion in the National Wound Care Strategy Programme consensus document Recommendations for lower limb ulcers [NWCSP, 2020], and on what CKS considers good clinical practice.

  • CKS notes that compression therapy is a long-term intervention which may require regular adjustment and as such, requires frequent review.
  • Wounds UK states that ongoing multidisciplinary support is required to maximise adherence and therapeutic outcomes for people using compression therapy [Wounds UK, 2023]. 

Supporting evidence

This CKS topic is largely based on the Wounds UK Best practice statement Compression hosiery; a patient-centric approach [Wounds UK, 2021], the Wounds UK Best Practice Statement The use of compression therapy for peripheral oedema: considerations in people with heart failure [Wounds UK, 2023], and the Wounds UK guidance Compression hosiery for the prevention of recurrent leg ulceration: Evidence, efficacy and best practice [Wounds UK, 2025], the National Wound Care Strategy Programme consensus document Recommendations for lower limb ulcers [NWCSP, 2020] , and the National Institute of Health and Care Excellence (NICE) HealthTech guidance Compression products for treating venous leg ulcers: late-stage assessment [NICE, 2025a], and evidence from high quality systematic reviews and meta-analyses. A brief summary of the available evidence is given in the relevant basis for recommendation sections. CKS has not summarized the evidence for secondary care investigations and management as they are beyond the scope of this topic.

How this topic was developed

This section briefly describes the processes used in developing and updating this topic. Further details on the full process can be found in the About Us section and on the Clarity Informatics website.

Search strategy

A literature search was conducted for guidelines, systematic reviews on the use of compression stockings in primary care.

Search dates

April 2022 - March 2026

Key search terms

Various combinations of searches were carried out. The terms listed below are the core search terms that were used for Medline.

  • exp Stockings, Compression/, (compression ADJ stocking$).tw., (compression ADJ hosiery or stocking or support or therapy).tw.
  • exp Varicose Veins/, varicose vein$.tw., exp Venous Insufficiency/, exp Scleroderma, Localized/, lipodermatosclerosis.tw., exp Varicose Ulcer/, venous ulcer.tw., venous eczema.tw., varicose eczema.tw.

Sources of guidelines

Sources of systematic reviews and meta-analyses

  • The Cochrane Library:
    • Systematic reviews
    • Protocols
    • Database of Abstracts of Reviews of Effects
  • Medline (with systematic review filter)
  • EMBASE (with systematic review filter)

Sources of health technology assessments and economic appraisals

Sources of randomized controlled trials

  • The Cochrane Library:
    • Central Register of Controlled Trials
  • Medline (with randomized controlled trial filter)
  • EMBASE (with randomized controlled trial filter)

Sources of evidence based reviews and evidence summaries

Sources of national policy

Patient experiences

Sources of medicines information

The following sources are used by CKS pharmacists and are not necessarily searched by CKS information specialists for all topics. Some of these resources are not freely available and require subscriptions to access content.

Stakeholder engagement

Our policy

The external review process is an essential part of CKS topic development. Consultation with a wide range of stakeholders provides quality assurance of the topic in terms of:

  • Clinical accuracy.
  • Consistency with other providers of clinical knowledge for primary care.
  • Accuracy of implementation of national guidance (in particular NICE guidelines).
  • Usability.

Principles of the consultation process

  • The process is inclusive and any individual may participate.
  • To participate, an individual must declare whether they have any competing interests or not. If they do not declare whether or not they have competing interests, their comments will not be considered.
  • Comments received after the deadline will be considered, but they may not be acted upon before the clinical topic is issued onto the website.
  • Comments are accepted in any format that is convenient to the reviewer, although an electronic format is encouraged.
  • External reviewers are not paid for commenting on the draft topics.
  • Discussion with an individual or an organization about the CKS response to their comments is only undertaken in exceptional circumstances (at the discretion of the Clinical Editor or Editorial Steering Group).
  • All reviewers are thanked and offered a letter acknowledging their contribution for the purposes of appraisal/revalidation.
  • All reviewers are invited to be acknowledged on the website. All reviewers are given the opportunity to feedback about the external review process, enabling improvements to be made where appropriate.

Stakeholders

  • Key stakeholders identified by the CKS team are invited to comment on draft CKS topics. Individuals and organizations can also register an interest to feedback on a specific topic, or topics in a particular clinical area, through the Getting involved section of the Clarity Informatics website.
  • Stakeholders identified from the following groups are invited to review draft topics:
    • Experts in the topic area.
    • Professional organizations and societies (for example, Royal Colleges).
    • Patient organizations, Clarity has established close links with groups such as Age UK and the Alzheimer’s Society specifically for their input into new topic development, review of current topic content and advice on relevant areas of expert knowledge.
    • Guideline development groups where the topic is an implementation of a guideline.
    • The British National Formulary team.
    • The editorial team that develop MeReC Publications.
  • Reviewers are provided with clear instructions about what to review, what comments are particularly helpful, how to submit comments, and declaring interests.

Patient engagement

Clarity Informatics has enlisted the support and involvement of patients and lay persons at all stages in the process of creating the content which include:

  • Topic selection
  • Scoping of topic
  • Selection of clinical scenarios
  • First draft internal review
  • Second draft internal review
  • External review
  • Final draft and pre-publication

Our lay and patient involvement includes membership on the editorial steering group, contacting expert patient groups, organizations and individuals.

Evidence exclusion criteria

Our policy

Scoping a literature search, and reviewing the evidence for CKS is a methodical and systematic process that is carried out by the lead clinical author for each topic. Relevant evidence is gathered in order that the clinical author can make fully informed decisions and recommendations. It is important to note that some evidence may be excluded for a variety of reasons. These reasons may be applied across all CKS topics or may be specific to a given topic.

Studies identified during literature searches are reviewed to identify the most appropriate information to author a CKS topic, ensuring any recommendations are based on the best evidence. We use the principles of the GRADE and PICOT approaches to assess the quality of published research. We use the principles of AGREE II to assess the quality of published guidelines.

Standard exclusions for scoping literature:

  • Animal studies
  • Original research is not written in English

Possible exclusions for reviewed literature:

  • Sample size too small or study underpowered
  • Bias evident or promotional literature
  • Population not relevant
  • Intervention/treatment not relevant
  • Outcomes not relevant
  • Outcomes have no clear evidence of clinical effectiveness
  • Setting not relevant
  • Not relevant to UK
  • Incorrect study type
  • Review article
  • Duplicate reference

Organizational, behavioural and financial barriers

Our policy

The CKS literature searches take into consideration the following concepts, which are discussed at the initial scoping of the topic.

  • Feasibility
    • Studies are selected depending on whether the intervention under investigation is available in the NHS and can be practically and safely undertaken in primary care.
  • Organizational and Financial Impact Analysis
  • Studies are selected and evaluated on whether the intervention under investigations may have an impact on local clinical service provision or national impact on cost for the NHS. The principles of clinical budget impact analysis are adhered to, evaluated and recorded by the author. The following factors are considered when making this assessment and analysis.
    • Eligible population
    • Current interventions
    • Likely uptake of new intervention or recommendation
    • Cost of the current or new intervention mix
    • Impact on other costs
    • Condition-related costs
    • In-direct costs and service impacts
    • Time dependencies
  • Cost-effectiveness or cost-benefit analysis studies are identified where available. 

We also evaluate and include evidence from NICE accredited sources which provide economic evaluations of recommendations, such as NICE guidelines. When a recommended action may not be possible because of resource constraints, this is explicitly indicated to healthcare professionals by the wording of the CKS recommendation.

Declarations of interest

Our policy

Clarity Informatics requests that all those involved in the writing and reviewing of topics, and those involved in the external review process to declare any competing interests. Signed copies are securely held by Clarity Informatics and are available on request with the permission of the individual. A copy of the declaration of interest form which participants are asked to complete annually is also available on request. A brief outline of the declarations of interest policy is described here and full details of the policy is available on the Clarity Informatics website. Declarations of interests of the authors are not routinely published, however competing interests of all those involved in the topic update or development are listed below. Competing interests include:

  • Personal financial interests
  • Personal family interest
  • Personal non-financial interest
  • Non-personal financial gain or benefit

Although particular attention is given to interests that could result in financial gains or losses for the individual, competing interests may also arise from academic competition or for political, personal, religious, and reputational reasons. An individual is not obliged to seek out knowledge of work done for, or on behalf of, the healthcare industry within the departments for which they are responsible if they would not normally expect to be informed.

Who should declare competing interests?

Any individual (or organization) involved in developing, reviewing, or commenting on clinical content, particularly the recommendations should declare competing interests. This includes the authoring team members, expert advisers, external reviewers of draft topics, individuals providing feedback on published topics, and Editorial Steering Group members. Declarations of interest are completed annually for authoring team and editorial steering group members, and are completed at the start of the topic update and development process for external stakeholders.

Competing interests declared for this topic:

None.

References

  • Azirar, S., Appelen, D., Prins, M.H., et al. (2019) Cochrane Review: Compression therapy for treating post‐thrombotic syndrome. Issue 9. John Wiley & Sons, Ltd. http://www.cochranelibrary.com [Free Full-text]
  • BLS (2019) Assessing vascular status in the presence of chronic oedema prior to the application of compression hosiery: position document to guide decision making. British Lymphology Society. http://www.thebls.com [Free Full-text]
  • BNF (2026) British National Formulary. National Institute for Health and Care Excellence. https://bnf.nice.org.uk [Free Full-text]
  • de Moraes Silva, M.A., Nelson, A., Bell-Syer, S.E., et al. (2024) Cochrane Review: Compression for preventing recurrence of venous ulcers. Issue 3 (3). John Wiley & Sons, Ltd. http://www.cochranelibrary.com [Free Full-text]
  • Di Nisio M, Wichers IM, Middeldorp S. (2018) Cochrane Review: Treatment for superficial thrombophlebitis of the leg. Issue 2. John Wiley & Sons, Ltd. http://www.cochranelibrary.com [Free Full-text]
  • Gornik, H.L., Aronow, H.D., Goodney, P.P., et al. (2025) 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 151(14), e918. [Abstract]
  • NICE (2020) Peripheral arterial disease: diagnosis and management. National Institute for Health and Care Excellence. https://www.nice.org.uk [Free Full-text]
  • NICE (2025a) Compression products for treating venous leg ulcers: late-stage assessment. National Institute for Health and Care Excellence. http://www.nice.org.uk [Free Full-text]
  • National Institute of Health and Care Excellence (NICE) (2025b) Varicose veins: diagnosis and management. NICE. http://www.nice.org.uk [Free Full-text]
  • NWCSP (2020) Recommendations for lower leg ulcers. National Wound Care Strategy Programme. http://www.nationalwoundcarestrategy.net [Free Full-text]
  • PPA (2022) NHS Electronic Drug Tariff: Part IXA-Appliances; Elastic Hoisery. Prescription Pricing Authority. http://www.drugtariff.nhsbsa.nhs.uk [Free Full-text]
  • Thapar, A., Lawton, R., Adamestam, I., et al. (2025) Compression Hosiery to Avoid the Post-Thrombotic Syndrome: a synopsis of the CHAPS RCT. Health Technol Assess. 66, 1-13. [Abstract]
  • Wounds UK; Fletcher, J., Atkin, L., Bolton, L., et al. (2021) Best Practice Statement: Compression hosiery: a patient-centric approach (third edition). Wounds UK. https://www.wounds-uk.com [Free Full-text]
  • Wounds UK (2023) Best Practice Statement: The use of compression therapy for peripheral oedema: considerations in people with heart failure. Wounds UK. https://wounds-uk.com [Free Full-text]
  • Wounds UK (2025) Compression hosiery for the prevention of recurrent leg ulceration: Evidence, efficacy and best practice. Woulds UK. http://www.wounds-uk.com [Free Full-text]
Change privacy settings